As of 2024-12-13, the Intrinsic Value of Biohaven Pharmaceutical Holding Company Ltd (BHVN) is -39.77 USD. This BHVN valuation is based on the model Peter Lynch Fair Value. With the current market price of 38.47 USD, the upside of Biohaven Pharmaceutical Holding Company Ltd is -203.38%.

Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.

	Range	Selected	Upside
a
Fair Value	-39.77 - -39.77	-39.77	-203.38%
P/E	(147.15) - (154.31)	(178.18)	-563.2%
DDM - Stable	(42.98) - (99.64)	(71.31)	-285.4%
DDM - Multi	(0.36) - (0.61)	(0.45)	-101.2%